CCR6 inhibitor 35

CAS No. ——

CCR6 inhibitor 35( —— )

Catalog No. M17039 CAS No. ——

CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCR6 inhibitor 35
  • Note
    Research use only, not for human use.
  • Brief Description
    CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6).
  • Description
    CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6); exhibits potent activity in the migration assay as well as the Gi signal assay with IC50 of <30 nM and 6 nM in human CCR6-transfected CHO cells, respectively, and displays high human CCR6 selectivity over human CCR1 and CCR7; potently inhibits CCR6-dependent cell migration and the increase in ERK phosphorylation in human primary cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    504.528
  • Molecular Formula
    C24H23F3N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-(4-(((1r,4r)-4-((5-(trifluoromethyl)pyridin-2-yl)amino)cyclohexyl)sulfonyl)phenyl)picolinamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tawaraishi T, et al. Bioorg Med Chem Lett. 2018 Jul 30. pii: S0960-894X(18)30637-1.
molnova catalog
related products
  • JNJ-27141491

    A potent, selective, noncompetitive, orally active CCR2 antagonist with IC50 of 172 nM.

  • CMPD167

    CMPD167 (MRK-1) is an orally acitve small molecule that binds to CCR5 to inhibit gp120 association.

  • E 6130

    A potent, selective, orally available CX3C chemokine receptor 1 (CX3CR1) modulator that inhibits the fractalkine-induced chemotaxis of human peripheral blood NK cells with IC50 of 4.9 nM.